← Back to Testing, Diagnosis and Treatment
Health guidanceUnited Kingdom with regional context

Why should laboratories report the Lyme testing algorithm?

Naming initial and supplemental methods lets clinicians understand validation, sequence and limitations.

Reviewed by VuxLore® Knowledge Team For Everyone

Short answer

Naming initial and supplemental methods lets clinicians understand validation, sequence and limitations.

At a glance

Naming initial and supplemental methods lets clinicians understand validation, sequence and limitations. Use validated pathways interpreted with symptoms, timing and exposure.

Key takeaways

• Naming initial and supplemental methods lets clinicians understand validation, sequence and limitations.

• Use validated pathways interpreted with symptoms, timing and exposure.

• This article is educational and cannot diagnose, exclude or treat illness. Use NHS 111, a GP, emergency services or the corresponding local service according to symptom severity.

Direct answer

Naming initial and supplemental methods lets clinicians understand validation, sequence and limitations.

Use it in context

Use validated pathways interpreted with symptoms, timing and exposure.

Practical next step

This article is educational and cannot diagnose, exclude or treat illness. Use NHS 111, a GP, emergency services or the corresponding local service according to symptom severity.

Sources and further reading

UK Lyme disease guidance and data

For current UK clinical advice, public-health guidance and surveillance data, consult these primary national sources.

  1. Lyme disease — NHS opens in a new tab ↗
  2. Lyme disease: diagnosis and management (NG95) — NICE opens in a new tab ↗
  3. Lyme disease: management and prevention — UKHSA opens in a new tab ↗
  4. Lyme disease surveillance dashboard — UKHSA opens in a new tab ↗
  5. Lyme disease — NHS Inform Scotland opens in a new tab ↗